Deal Snapshot: Celldex Buys Immune Modulating Molecules Exclusive Rights From Amgen
M & A Navigator › July 31, 2010
Linked as:
Summary
MANAVIGATOR-April 9, 2009-Deal snapshot: CELLDEX BUYS IMMUNE MODULATING MOLECULES EXCLUSIVE RIGHTS FROM AMGEN (C)2010 M2 COMMUNICATIONS http://www.m2.com
US biopharmaceutical company Celldex Therapeutics (NASDAQ: CLDX) said it has acquired the exclusive rights to the Flt3L and CD40L immune modulating molecules from local sector player Amgen (NASDAQ:AMGN).See the full content of this document
Extract
Deal Snapshot: Celldex Buys Immune Modulating Molecules Exclusive Rights From Amgen
Country: USA...
See the full content of this document
Sponsored links
